- Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results
Cardiovascular Research · 2020
- Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
Cardiovascular Diabetology · 2020
- Can genetic testing help in the management of dyslipidaemias?
Current Opinion in Lipidology · 2020
- Cardiovascular events following pregnancy complicated by pre‐eclampsia with emphasis on comparison between early‐ and late‐onset forms: systematic review and meta‐analysis
Ultrasound in Obstetrics and Gynecology · 2020
- Nationwide Trends in Prevalent Cardiovascular Risk Factors and Diseases in Young Adults: Differences by Sex and Race and In-Hospital Outcomes
Southern Medical Journal · 2020
- EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)
Eurasian heart journal · 2020
- Lipid profile and left ventricular geometry pattern in obese children
Lipids in Health and Disease · 2020
- Progress in the seasonal variations of blood lipids: a mini-review
Lipids in Health and Disease · 2020
- Comanagement of Risk Factors in Patients With Coronary Artery Disease: Insights From the APPEAR Study
Journal of the American Heart Association · 2020
- The role of the Clinical Chemistry laboratory in facilitating earlier diagnosis of dyslipidaemia-associated inherited metabolic disease
Journal of Clinical Pathology · 2020
- Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway
BMC Cardiovascular Disorders · 2020
- P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance
Frontiers in Endocrinology · 2020
- Increased atherogenic lipoprotein profile in children with non‐alcoholic steatohepatitis
Pediatric Obesity · 2020
- Effectiveness of Fimasartan and Rosuvastatin Combination Treatment in Hypertensive Patients With Dyslipidemia
Clinical Therapeutics · 2020
- Community intervention for cardiovascular disease risk factors in Kalutara, Sri Lanka
BMC Cardiovascular Disorders · 2020
- Lipoprotein(a) and Cardiovascular Diseases ― Revisited ―
Circulation Journal · 2020
- The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects
Lipids in Health and Disease · 2020
- Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
International Journal of Molecular Sciences · 2020
- Impact of Mean and Variability of High‐Density Lipoprotein‐Cholesterol on the Risk of Myocardial Infarction, Stroke, and Mortality in the General Population
Journal of the American Heart Association · 2020
- Short-Term Progression of Multiterritorial Subclinical Atherosclerosis
Journal of the American College of Cardiology · 2020
- Association of angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensinogen (AGT M235T) polymorphisms with the risk of obesity in a Tunisian population
Journal of the Renin-Angiotensin-Aldosterone System · 2020
- Effect of inclisiran, the small-interfering RNA against proprotein convertase subtilisin/kexin type 9, on platelets, immune cells, and immunological biomarkers: a pre-specified analysis from ORION-1
Cardiovascular Research · 2020
- Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome
Circulation · 2020
- A Narrative Review and Expert Panel Recommendations on Dyslipidaemia Management After Acute Coronary Syndrome in Countries Outside Western Europe and North America
Advances in Therapy · 2020
- The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Circulation · 2020
- Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis
High Blood Pressure & Cardiovascular Prevention · 2020
- Comparison of Short and Long-Term Outcomes of Metabolic and Bariatric Surgery in Adolescents and Adults
Frontiers in Endocrinology · 2020
- Ageing, obesity, dyslipidaemia, and hospital-room hypertension are clinical risk factors relating to pre-anaesthesia
Anaesthesiology Intensive Therapy · 2020
- Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation
Hypertension · 2020
- Heart rate as cardiovascular risk factor
Postgraduate Medicine · 2020
- Associations of Serum Uric Acid with Endogenous Cholesterol Synthesis Indices in Men with High Cardiometabolic Risk
Metabolic Syndrome and Related Disorders · 2020
- Patient-level factors influencing hypertension control in adults in Accra, Ghana
BMC Cardiovascular Disorders · 2020
- Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
BMC Cardiovascular Disorders · 2020
- Swine Disease Models for Optimal Vascular Engineering
Annual Review of Biomedical Engineering · 2020
- High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
Metabolic Syndrome and Related Disorders · 2020
- Annual rates of and factors influencing inpatient and outpatient transient ischaemic attacks in Chinese population: a nationally representative cross-sectional survey
BMJ Open · 2020
- Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
European Heart Journal - Quality of Care and Clinical Outcomes · 2020
- Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012
Salud Pública de México · 2020
- Efficacy of Chinese prescription Kangen-karyu for patient with metabolic syndrome
Drug Discoveries & Therapeutics · 2020
- The brave new world of genetic testing in the management of the dyslipidaemias
Current Opinion in Cardiology · 2020
- 18α-Glycyrrhetinic acid (GA) ameliorates fructose-induced nephropathy in mice by suppressing oxidative stress, dyslipidemia and inflammation
Biomedicine & Pharmacotherapy · 2020
- Status of dyslipidemia management and statin undertreatment in Korean cancer survivors: A Korean National Health and Nutrition Examination Survey study
European Journal of Preventive Cardiology · 2020
- Heparin‐induced lipoprotein precipitation apheresis in dyslipidemic patients: A multiparametric assessment
Journal of Clinical Apheresis · 2020
- The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China
Cardiovascular Diabetology · 2020
- Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases
Metabolic Syndrome and Related Disorders · 2020
- Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?
European Heart Journal · 2020
- Lipids and antithrombotic treatment
European Heart Journal - Cardiovascular Pharmacotherapy · 2020
- Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study
Journal of the American Heart Association · 2020
- Maternal Cardiovascular Disease 3 Decades After Preterm Birth
Hypertension · 2020
- Urinary Albumin, Sodium, and Potassium and Cardiovascular Outcomes in the UK Biobank
Hypertension · 2020